APR 20 Pill - brown four-sided
Generic Name: apremilast
Pill with imprint APR 20 is Brown, Four-sided and has been identified as Otezla 20 mg. It is supplied by Celgene Corporation.
Otezla is used in the treatment of Psoriatic Arthritis; Behcet's Disease; Plaque Psoriasis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Otezla 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APR 20
Otezla
- Generic Name
- apremilast
- Imprint
- APR 20
- Strength
- 20 mg
- Color
- Brown
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59572-0630 | Celgene Corporation |
| 59572-0632 (Discontinued) | Celgene Corporation |
Related images for "APR 20"
More about Otezla (apremilast)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (440)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.